Advanced Therapies USA 2026 in Boston

Advanced Therapies USA returns to Boston on November 4-5, 2026 as America's most exciting commercial cell and gene therapy conference and exhibition. Designed for leaders of pioneering ATMP companies, the event brings together 1,200 global executives, 200 speakers and 50 biotech start-ups across two intensive days at the Hynes Convention Center. The programme spans the entire value chain of cell and gene therapy development, with eight tracks of content covering evidence, pricing and access, gene modified cell therapy, cell therapy, gene therapy, manufacturing, supply chain and an innovation showcase. Session topics include autologous versus allogeneic approaches, CAR-T and NK cells, gene editing, viral vector manufacturing, cold chain logistics and point-of-care delivery. Attendees include forward-thinking pharma, biotech and start-up companies, researchers, clinicians, academics, HTAs, payers and regulators. With 12+ hours of built-in 1-2-1 networking, 50 solution providers on the exhibition floor and a dedicated Clinician Hub, the congress is the annual meeting point for the advanced therapies community in the United States.